Resonant Capital Advisors’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,772
Closed -$271K 232
2021
Q4
$271K Sell
10,772
-4,953
-31% -$125K 0.04% 180
2021
Q3
$398K Hold
15,725
0.07% 146
2021
Q2
$399K Buy
15,725
+198
+1% +$5.03K 0.08% 131
2021
Q1
$395K Hold
15,527
0.08% 125
2020
Q4
$397K Hold
15,527
0.09% 119
2020
Q3
$398K Buy
15,527
+3,696
+31% +$94.8K 0.11% 103
2020
Q2
$304K Sell
11,831
-51,246
-81% -$1.3M 0.09% 141
2020
Q1
$1.56M Sell
63,077
-12,521
-17% -$314K 0.57% 56
2019
Q4
$1.91M Buy
+75,598
New +$1.91M 0.6% 50

Other funds holding IBDN

Resonant Capital Advisors's IBDN Position: Q1 2022 in Review

Resonant Capital Advisors sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q1 2022, closing a stake of 10,772 shares — an estimated $271K sold.

Resonant Capital Advisors first reported a position in IBDN in Q4 2019 and held it in 9 quarters. The position peaked at $1.91M in Q4 2019. 200 funds tracked by Wall St. Rank hold IBDN as of Q1 2022.

  • Resonant Capital Advisors reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q1 2022 after selling out during the quarter.
  • Resonant Capital Advisors sold 10,772 iShares iBonds Dec 2022 Term Corporate ETF shares in Q1 2022, an estimated $271K.
  • Resonant Capital Advisors first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q4 2019 and held it in 9 quarters.
  • Resonant Capital Advisors's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $1.91M in Q4 2019.
  • 200 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q1 2022.

Based on Resonant Capital Advisors's 13F filing for Q1 2022, filed 19 Apr 2022.